minoxidil has been researched along with Chronic Illness in 15 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of a 3 percent topical minoxidil solution (2,4-diamino-6-piperidinopyrimidine-3-oxide) in a propylene glycol-water-ethanol base applied twice daily for one year to half the scalp was evaluated in patients with severe chronic alopecia areata." | 10.16 | 3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata. ( Fransway, AF; Muller, SA, 1988) |
| "Topically administered minoxidil is of equal efficacy as diltiazem in the treatment of chronic anal fissure with low frequency of adverse effects." | 9.27 | Topical Minoxidil Versus Topical Diltiazem for Chemical Sphincterotomy of Chronic Anal Fissure: A Prospective, Randomized, Double-Blind, Clinical Trial. ( Ala, S; Alvandipour, M; Khalvati, M; Koulaeinejad, N; Yazdanicharati, J, 2018) |
| "Topical diphenylcyclopropenone (DPCP) and minoxidil have been used in the treatment of alopecia areata with variable results." | 9.07 | Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation. ( Abbott, F; Ho, V; Shapiro, J; Tan, J; Tron, V, 1993) |
| "Minoxidil in combination with propranolol and diuretics was used in the treatment of 41 patients with severe refractory hypertension due to a spectrum of causes." | 7.66 | Minoxidil in the treatment of refractory hypertension due to a spectrum of causes. ( Amend, WJ; McChesney, JA, 1980) |
| "The efficacy of a 3 percent topical minoxidil solution (2,4-diamino-6-piperidinopyrimidine-3-oxide) in a propylene glycol-water-ethanol base applied twice daily for one year to half the scalp was evaluated in patients with severe chronic alopecia areata." | 6.16 | 3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata. ( Fransway, AF; Muller, SA, 1988) |
| "Topically administered minoxidil is of equal efficacy as diltiazem in the treatment of chronic anal fissure with low frequency of adverse effects." | 5.27 | Topical Minoxidil Versus Topical Diltiazem for Chemical Sphincterotomy of Chronic Anal Fissure: A Prospective, Randomized, Double-Blind, Clinical Trial. ( Ala, S; Alvandipour, M; Khalvati, M; Koulaeinejad, N; Yazdanicharati, J, 2018) |
| "Topical diphenylcyclopropenone (DPCP) and minoxidil have been used in the treatment of alopecia areata with variable results." | 5.07 | Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation. ( Abbott, F; Ho, V; Shapiro, J; Tan, J; Tron, V, 1993) |
| "Minoxidil in combination with propranolol and diuretics was used in the treatment of 41 patients with severe refractory hypertension due to a spectrum of causes." | 3.66 | Minoxidil in the treatment of refractory hypertension due to a spectrum of causes. ( Amend, WJ; McChesney, JA, 1980) |
| "A patient with severe, chronic congestive heart failure was unresponsive not only to conventional therapy, but also to nonparenteral nitroglycerin and isosorbide dinitrate; he became nitroprusside dependent." | 3.65 | Combination vasodilator therapy for severe chronic congestive heart failure. ( Chatterjee, K; Drew, D; Klausner, SC; Parmley, WW; Polansky, J; Zacherle, B, 1976) |
| "The scheme of hair loss treatment, by means of preparations affecting pathogenetical mechanisms of diffuse hair loss development is offered." | 2.73 | [Effectiveness of the treatment plan for androgenetic alopecia]. ( Tsiskarishvili, NV; Tsiskarishvili, TsI, 2007) |
| "Nine healthy men with type IVa or Va male pattern baldness completed a 4-month single-blinded controlled pilot study designed to assess the effect of ultraviolet light (UVL) on topical minoxidil-induced hair growth." | 2.66 | Effect of ultraviolet light on topical minoxidil-induced hair growth in advanced male pattern baldness. ( Delong, ER; Murray, JC; Olsen, EA; Pestana, A, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (66.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Emile, SH | 1 |
| Abdel-Razik, MA | 1 |
| Elshobaky, A | 1 |
| Elbaz, SA | 1 |
| Khafagy, W | 1 |
| Shalaby, M | 1 |
| Alvandipour, M | 1 |
| Ala, S | 1 |
| Khalvati, M | 1 |
| Yazdanicharati, J | 1 |
| Koulaeinejad, N | 1 |
| Iorizzo, M | 1 |
| Tosti, A | 1 |
| Tsiskarishvili, NV | 1 |
| Tsiskarishvili, TsI | 1 |
| McChesney, JA | 1 |
| Amend, WJ | 1 |
| Schwartz, AB | 1 |
| Chatterjee, K | 2 |
| Satinsky, JD | 1 |
| Shapiro, J | 1 |
| Tan, J | 1 |
| Ho, V | 1 |
| Abbott, F | 1 |
| Tron, V | 1 |
| Drew, D | 1 |
| Parmley, WW | 1 |
| Klausner, SC | 1 |
| Polansky, J | 1 |
| Zacherle, B | 1 |
| Fransway, AF | 1 |
| Muller, SA | 1 |
| Pestana, A | 1 |
| Olsen, EA | 1 |
| Delong, ER | 1 |
| Murray, JC | 1 |
| Leshchinskiĭ, PM | 1 |
| Makarova, NA | 1 |
| Almazov, II | 1 |
| Arabidze, GG | 1 |
| Strife, CF | 1 |
| Quinlan, M | 1 |
| Waldo, FB | 1 |
| Fryer, CJ | 1 |
| Jackson, EC | 1 |
| Welch, TR | 1 |
| McEnery, PT | 1 |
| West, CD | 1 |
| Liebau, G | 1 |
| Hayduk, K | 1 |
| Bundschu, HD | 1 |
| Menz, HP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Topical 5% Minoxidil Versus 0.2%Topical Glyceryl Trinitrate in Treatment of Chronic Anal Fissure: a Randomized Controlled Trial[NCT03528772] | 62 participants (Actual) | Interventional | 2018-05-10 | Completed | |||
| The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata[NCT00999869] | 20 participants (Anticipated) | Interventional | 2009-11-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for minoxidil and Chronic Illness
| Article | Year |
|---|---|
Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment.
Topics: 5-alpha Reductase Inhibitors; Administration, Topical; Alopecia; Calcineurin Inhibitors; Chronic Dis | 2019 |
Vasodilator therapy in chronic congestive heart failure.
Topics: Captopril; Chronic Disease; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralaz | 1983 |
3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata.
Topics: Administration, Topical; Adult; Alopecia Areata; Chronic Disease; Clinical Trials as Topic; Double-B | 1988 |
6 trials available for minoxidil and Chronic Illness
| Article | Year |
|---|---|
Topical 5% minoxidil versus topical 0.2% glyceryl trinitrate in treatment of chronic anal fissure: A randomized clinical trial.
Topics: Administration, Topical; Adult; Chronic Disease; Female; Fissure in Ano; Humans; Male; Middle Aged; | 2020 |
Topical Minoxidil Versus Topical Diltiazem for Chemical Sphincterotomy of Chronic Anal Fissure: A Prospective, Randomized, Double-Blind, Clinical Trial.
Topics: Administration, Topical; Adolescent; Adult; Blood Pressure; Chronic Disease; Diltiazem; Double-Blind | 2018 |
[Effectiveness of the treatment plan for androgenetic alopecia].
Topics: Adolescent; Adult; Alopecia; Antifungal Agents; Chronic Disease; Enzyme Inhibitors; Female; Finaster | 2007 |
Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
Topics: Administration, Cutaneous; Adult; Aged; Alopecia; Antibodies, Monoclonal; Antigens, CD; CD4 Antigens | 1993 |
3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata.
Topics: Administration, Topical; Adult; Alopecia Areata; Chronic Disease; Clinical Trials as Topic; Double-B | 1988 |
Effect of ultraviolet light on topical minoxidil-induced hair growth in advanced male pattern baldness.
Topics: Adult; Alopecia; Chronic Disease; Clinical Trials as Topic; Combined Modality Therapy; Humans; Male; | 1987 |
7 other studies available for minoxidil and Chronic Illness
| Article | Year |
|---|---|
Minoxidil in the treatment of refractory hypertension due to a spectrum of causes.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Pressure; Cerebrovascular Disorders; Chronic Disease; | 1980 |
Chronic heart failure in the elderly: vasodilator therapy.
Topics: Aged; Blood Pressure; Chronic Disease; Female; Follow-Up Studies; Heart Failure; Humans; Hydralazine | 1983 |
Combination vasodilator therapy for severe chronic congestive heart failure.
Topics: Chronic Disease; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosor | 1976 |
[Clinical effectiveness of minoxidil in patients with severe forms of arterial hypertension].
Topics: Adult; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Furosemide; Humans; Hype | 1988 |
Minoxidil for control of acute blood pressure elevation in chronically hypertensive children.
Topics: Adolescent; Blood Pressure; Child; Child, Preschool; Chronic Disease; Humans; Hypertension; Kidney F | 1986 |
Refractory hypertension.
Topics: Administration, Oral; Antihypertensive Agents; Chronic Disease; Diazoxide; Drug Combinations; Drug R | 1973 |
[Clinical experiences with minoxidil, a new antihypertensive agent].
Topics: Chronic Disease; Humans; Hypertension; Minoxidil; Pyrimidines | 1974 |